Skip to main content

Part of the book series: Clinical Gastroenterology ((CG))

  • 165 Accesses

Abstract

Portal hypertension, defined as sustained elevation of the portal pressure above 12 mmHg, can arise from a myriad of causes. In Western countries, the most common cause is alcoholic liver cirrhosis, whereas in Asia, and developing countries, it is postnecrotic cirrhosis (from viral hepatitis) and schistosomiasis. The adverse effects of chronic portal hypertension include the formation of esophageal, and extraesophageal varices, ascites, splenomegaly with hypersplenism, hepatorenal syndrome, and hepatic encephalopathy. Hemorrhage from gastroesophageal varices is the most lethal of these complications. Thus, its prevention and treatment has assumed paramount importance in the management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. De Francis R, et al. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319: 983 - 989.

    Article  Google Scholar 

  2. Gores GJ, Wiesner RH, Dickson ER, et al. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence on survival. Gastroenterology 1989; 96: 1552 - 1559.

    PubMed  CAS  Google Scholar 

  3. Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800 - 809.

    PubMed  CAS  Google Scholar 

  4. Child CG. Eck' s fistula. Surg Gynecol Obstet. 1953;96:375-376. Originally published in Russian: Eck NV. K voprosu o perevyazkie vorotnois veni: predvaritelnoye soobshtshjenye. Voen Med J. 1877; 130: 1 - 2.

    Google Scholar 

  5. Donovan AJ, Covey PC. Early history of the portacaval shunt in humans. Surg Gynecol Obstet. 1978;147:423-430. Originally published in French: Vidal. Traitment chirurgical des ascites dans les cirrhoses du foie. 16th Cong Fr Chir 1903; 16: 294 - 304.

    Google Scholar 

  6. Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg 1945; 122: 449 - 475.

    Article  PubMed  CAS  Google Scholar 

  7. Linton RR, Jones CM, Volwiler W. Portal hypertension: the treatment by splenectomy and splenorenal anastomosis with preservation of the kidney. Surg Clin North Am 1947; 27: 1162 - 1170.

    PubMed  CAS  Google Scholar 

  8. Bismuth H, Franco D, Hepp J. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical result? Ann Surg 1974; 179: 209 - 218.

    Article  PubMed  CAS  Google Scholar 

  9. Sarfeh IJ, Rypins EB, Conroy RM, et al. Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy. Ann Surg 1983; 197: 422 - 426.

    Article  PubMed  CAS  Google Scholar 

  10. Rypins EB, Mason GR, Conroy RM, et al. Predictability and maintenance of portal flow patterns after small-diameter porta-caval H-grafts in man. Ann Surg 1984; 200: 706 - 710.

    Article  PubMed  CAS  Google Scholar 

  11. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219: 353 - 361.

    Article  PubMed  CAS  Google Scholar 

  12. Paquet KJ, Lazar A, Koussouris P, et al. Mesocaval interposition shunt with small diameter polytetrafluoroethylene grafts in sclerotherapy failure. Brit J Surg 1995; 82: 199 - 203.

    Article  PubMed  CAS  Google Scholar 

  13. Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967; 166: 437 - 455.

    Article  PubMed  CAS  Google Scholar 

  14. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332 - 354.

    Article  PubMed  Google Scholar 

  15. van der Vliet JA, De Visser E, Buskens FGM. Changing pattern of portasystemic shunt surgery. Eur J Surg 1995; 161: 877 - 880.

    PubMed  CAS  Google Scholar 

  16. McCormick PA, Burroughs AK. Relation between liver pathology and prognosis in patients with portal hypertension. World J. Surg 1994; 18: 171 - 175.

    Google Scholar 

  17. Millikan WJ, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding: ten-year follow-up. Ann Surg 1985; 201: 712 - 722.

    Article  PubMed  Google Scholar 

  18. Warren WD, Millikan WJ, Henderson JM, et al. Ten years portal hypertensive surgery at Emory: results and new perspectives. Ann Surg 1982; 195: 530 - 542.

    Article  PubMed  CAS  Google Scholar 

  19. Inokuchi K, Beppu K, Koyanagi N, et al. Exclusion of nonisolated splenic vein in distal splenorenal shunt for prevention of portal malcirculation. Ann Surg 1984; 200: 711 - 717.

    Article  PubMed  CAS  Google Scholar 

  20. Warren WD, Millikan WJ, Henderson JM, et al. Splenopancreatic disconnection. Improved selectivity of distal splenorenal shunt. Ann Surg 1986; 204: 346 - 355.

    Article  PubMed  CAS  Google Scholar 

  21. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204: 356 - 363.

    Article  PubMed  CAS  Google Scholar 

  22. Orozco H, Mercado MA. The evolution of portal hypertension surgery. Lessons from 1000 operations and 50 years' experience. Arch Surg 2000; 135: 1389 - 1393.

    Article  PubMed  CAS  Google Scholar 

  23. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219: 353 - 361.

    Article  PubMed  CAS  Google Scholar 

  24. Millikan WJ, Warren WD, Henderson JM, et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten-year follow-up. Ann Surg 1985; 201: 712 - 722.

    Article  PubMed  Google Scholar 

  25. Mercado MA, Morales-Linares JC, Granados-Garcia J, et al. Distal splenorenal shunt versus 10-mm low-diameter mesocaval shunt for variceal hemorrhage. Am J Surg 1996; 171: 591 - 595.

    Article  PubMed  CAS  Google Scholar 

  26. Richards WO, Pearson TC, Henderson JM, et al. Evaluation and treatment of early hemorrhage of the alimentary tract after selective shunt procedures. Surg Gynecol Obstet 1987; 164: 530 - 536.

    PubMed  CAS  Google Scholar 

  27. Henderson JM, Millikan WJ, Galloway JR. The Emory perspective of the distal splenorenal shunt in 1990. Am J Surg 1990; 160: 54 - 59.

    Article  Google Scholar 

  28. Richards WO, Pearson TC, Henderson JM, et al. Evaluation and treatment of early hemorrhage of the alimentary tract after selective shunt procedures. Surg Gynecol Obstet 1987; 164: 530.

    PubMed  CAS  Google Scholar 

  29. Henderson JM, Gong-Liang J, Galloway J, et al. Portaprival collaterals following distal splenorenal shunt: incidence, magnitude and associated portal perfusion changes. J Hepatol 1985; 1: 649 - 661.

    Article  PubMed  CAS  Google Scholar 

  30. Henderson JM, Warren WD, Millikan WJ, et al. Distal splenorenal shunt with splenopancreatic disconnection: a four year assessment. Ann Surg 1989; 210: 332 - 341.

    Article  PubMed  CAS  Google Scholar 

  31. Orozco H, Mercado MA, Takahashi T, et al. Survival and quality of life after portal blood flow preserving procedures in patients with portal hypertension and liver cirrhosis. Am J Surg 1994; 168: 10 - 14.

    Article  PubMed  CAS  Google Scholar 

  32. Collins JC, Rypins EB, Sarfeh U. Narrow-diameter portacaval shunts for management of variceal bleeding. World J Surg 1994; 18: 211 - 215.

    Article  PubMed  CAS  Google Scholar 

  33. Paquet KJ, Lazar A, Koussouris P, et al. Mesocaval interposition shunt with small-diameter polytetrafluoroethylene grafts in sclerotherapy failure. Brit J Surg 1995; 82: 199 - 203.

    Article  PubMed  CAS  Google Scholar 

  34. Rosemurgy AS, McAllister EW, Kearney RE. Prospective study of a prosthetic H-graft portacaval shunt. Am J Surg 1991; 161: 159.

    Article  PubMed  CAS  Google Scholar 

  35. Spina GP, Henderson JM, Rikkers LF, et al. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention variceal bleeding: a meta-analysis of 4 randomized clinical trials. J Hepatol 1992; 16: 338.

    Article  PubMed  CAS  Google Scholar 

  36. Snady H. The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials. Am J Gastroenterology 1987; 82: 813 - 822.

    CAS  Google Scholar 

  37. Rikkers LF, Jin G, Burnett DA, et al. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1992; 165: 27 - 33.

    Article  Google Scholar 

  38. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portasystemic shunts. Gastroenterology 1997; 112: 889 - 898.

    Article  PubMed  CAS  Google Scholar 

  39. Rosemurgy AS, Goode SE, Zwiebel BR, et al. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224: 378 - 386.

    Article  PubMed  CAS  Google Scholar 

  40. Khaitiyar JS, Luthra SK, Prasad N, et al. Transjugular intrahepatic portasystemic shunt versus distal splenorenal shunt - a comparative study. Hepato-gastroenterology 2000; 47: 492 - 497.

    PubMed  CAS  Google Scholar 

  41. Helton WS, Mayes R, Wicks K. Transjugular intrahepatic portasystemic shunt versus surgical shunt in good-risk cirrhotic patients. Arch Surg 2001; 136: 17 - 20.

    Article  PubMed  CAS  Google Scholar 

  42. Zacks SL, Sandler RS, Biddle AK, et al. Decision-analysis of transjugular intrahepatic portasystemic shunt versus distal splenorenal shunt for portal hypertension. Hepatology 1999; 29: 1399 - 1405.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chew, D.K.W., Conte, M.S. (2003). Portasystemic Venous Shunt Surgery for Portal Hypertension. In: Wu, G.Y., Aziz, K., Whalen, G.F. (eds) An Internist’s Illustrated Guide to Gastrointestinal Surgery. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-389-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-389-7_24

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-311-4

  • Online ISBN: 978-1-59259-389-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics